Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Breast Cancer

  Free Subscription


16.04.2018

1 AJR Am J Roentgenol
2 Ann Oncol
1 Ann Surg Oncol
1 Anticancer Res
1 BMC Cancer
3 Breast Cancer
1 Breast Cancer Res
6 Breast Cancer Res Treat
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
1 Clin Breast Cancer
1 Clin Cancer Res
1 Curr Treat Options Oncol
2 Eur J Cancer
1 Eur J Surg Oncol
1 Eur Radiol
2 Int J Cancer
1 J Clin Invest
1 J Surg Oncol
1 NPJ Breast Cancer
4 PLoS One
4 Radiology
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ROSE SL, Shisler JL
    Tomosynthesis Impact on Breast Cancer Screening in Patients Younger Than 50 Years Old.
    AJR Am J Roentgenol. 2018 Apr 9:1-4. doi: 10.2214/AJR.17.18839.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. CRUZ C, Castroviejo-Bermejo M, Gutierrez-Enriquez S, Llop-Guevara A, et al
    RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA mutated breast cancer.
    Ann Oncol. 2018 Apr 4. pii: 4959904. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. GEFFEN DB
    Should decisions on adding adjuvant chemotherapy in early stage ER positive breast cancer be based on gene expression testing or clinicopathologic factors or both?
    Ann Oncol. 2018 Apr 4. pii: 4959909. doi: 10.1093.
    PubMed     Text format    


    Ann Surg Oncol

  4. EXMAN P, Burstein HJ
    How Old is Too Old? Breast Cancer Treatment in Octogenarians.
    Ann Surg Oncol. 2018 Apr 9. pii: 10.1245/s10434-018-6457.
    PubMed     Text format    


    Anticancer Res

  5. PARK HL, Kim KY, Park JS, Shin JE, et al
    Clinicopathological Analysis of Ultrasound-guided Vacuum-assisted Breast Biopsy for the Diagnosis and Treatment of Breast Disease.
    Anticancer Res. 2018;38:2455-2462.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. XIAO B, Chen L, Ke Y, Hang J, et al
    Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
    BMC Cancer. 2018;18:405.
    PubMed     Text format     Abstract available


    Breast Cancer

  7. LI Q, Gao H, Zhou S, Liao Y, et al
    LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-beta1 and downregulating PHGDH.
    Breast Cancer. 2018 Apr 6. pii: 10.1007/s12282-018-0858.
    PubMed     Text format     Abstract available

  8. NAZARI SS, Mukherjee P
    An overview of mammographic density and its association with breast cancer.
    Breast Cancer. 2018 Apr 12. pii: 10.1007/s12282-018-0857.
    PubMed     Text format     Abstract available

  9. OHASHI R, Nagao M, Nakamura I, Okamoto T, et al
    Improvement in diagnostic performance of breast cancer: comparison between conventional digital mammography alone and conventional mammography plus digital breast tomosynthesis.
    Breast Cancer. 2018 Apr 12. pii: 10.1007/s12282-018-0859.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  10. CABRERA RM, Mao SPH, Surve CR, Condeelis JS, et al
    A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration.
    Breast Cancer Res. 2018;20:24.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  11. LARSEN SB, Torstensson M, Kenborg L, Christensen J, et al
    Pre-diagnostic changes in body mass index and mortality among breast cancer patients.
    Breast Cancer Res Treat. 2018 Apr 10. pii: 10.1007/s10549-018-4771.
    PubMed     Text format     Abstract available

  12. KUROZUMI S, Joseph C, Sonbul S, Gorringe KL, et al
    Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
    Breast Cancer Res Treat. 2018 Apr 9. pii: 10.1007/s10549-018-4777.
    PubMed     Text format     Abstract available

  13. GUINTER MA, McLain AC, Merchant AT, Sandler DP, et al
    An estrogen-related lifestyle score is associated with risk of postmenopausal breast cancer in the PLCO cohort.
    Breast Cancer Res Treat. 2018 Apr 12. pii: 10.1007/s10549-018-4784.
    PubMed     Text format     Abstract available

  14. VERMA S, O'Shaughnessy J, Burris HA, Campone M, et al
    Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2.
    Breast Cancer Res Treat. 2018 Apr 13. pii: 10.1007/s10549-018-4769.
    PubMed     Text format     Abstract available

  15. SOARES FALCETTA F, de Araujo Vianna Trasel H, de Almeida FK, Rangel Ribeiro Falcetta M, et al
    Effects of physical exercise after treatment of early breast cancer: systematic review and meta-analysis.
    Breast Cancer Res Treat. 2018 Apr 13. pii: 10.1007/s10549-018-4786.
    PubMed     Text format     Abstract available

  16. ARTHUR R, Wang Y, Ye K, Glass AG, et al
    Correction to: Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.
    Breast Cancer Res Treat. 2018 Apr 11. pii: 10.1007/s10549-018-4780.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  17. MADSEN MJ, Knight S, Sweeney C, Factor RE, et al
    Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genomewide significant breast cancer locus at 12q15.
    Cancer Epidemiol Biomarkers Prev. 2018 Apr 12. pii: 1055-9965.EPI-17-0887.
    PubMed     Text format     Abstract available


    Cancer Lett

  18. OJO D, Lin X, Wu Y, Cockburn J, et al
    Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer.
    Cancer Lett. 2018;426:4-13.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  19. TAHERIPANAH R, Balash F, Anbiaee R, Mahmoodi M, et al
    Breast Cancer and Ovulation Induction Treatments.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30455.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  20. WEST DC, Kocherginsky M, Tonsing-Carter EY, Dolcen DN, et al
    Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer.
    Clin Cancer Res. 2018 Apr 10. pii: 1078-0432.CCR-17-2793.
    PubMed     Text format     Abstract available


    Curr Treat Options Oncol

  21. ZIMMER AS, Gillard M, Lipkowitz S, Lee JM, et al
    Update on PARP Inhibitors in Breast Cancer.
    Curr Treat Options Oncol. 2018;19:21.
    PubMed     Text format     Abstract available


    Eur J Cancer

  22. JACQUET E, Lardy-Cleaud A, Pistilli B, Franck S, et al
    Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients.
    Eur J Cancer. 2018;95:93-101.
    PubMed     Text format     Abstract available

  23. BLOK EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, et al
    Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer.
    Eur J Cancer. 2018;95:59-67.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  24. VICINI E, Invento A, Cuoghi M, Bafile A, et al
    Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey.
    Eur J Surg Oncol. 2018 Mar 31. pii: S0748-7983(18)30987.
    PubMed     Text format     Abstract available


    Eur Radiol

  25. KIM WH, Cho N, Kim YS, Yi A, et al
    Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.
    Eur Radiol. 2018 Apr 6. pii: 10.1007/s00330-017-5293.
    PubMed     Text format     Abstract available


    Int J Cancer

  26. CAO C, Wu H, Vasilatos SN, Chandran U, et al
    HDAC5-LSD1 Axis Regulates Antineoplastic Effect of Natural HDAC Inhibitor Sulforaphane in Human Breast Cancer Cells.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31419.
    PubMed     Text format     Abstract available

  27. NJOR SH, Paci E, Rebolj M
    As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31420.
    PubMed     Text format     Abstract available


    J Clin Invest

  28. CHEN Y, Zhang B, Bao L, Jin L, et al
    ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.
    J Clin Invest. 2018 Apr 9. pii: 95089. doi: 10.1172/JCI95089.
    PubMed     Text format     Abstract available


    J Surg Oncol

  29. SO A, De La Cruz LM, Williams AD, Bahng J, et al
    The impact of preoperative magnetic resonance imaging and lumpectomy cavity shavings on re-excision rate in pure ductal carcinoma in situ-A single institution's experience.
    J Surg Oncol. 2018;117:558-566.
    PubMed     Text format     Abstract available


    NPJ Breast Cancer

  30. JATOI I, Benson JR, Kunkler I
    Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality?
    NPJ Breast Cancer. 2018;4:8.
    PubMed     Text format     Abstract available


    PLoS One

  31. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    PubMed     Text format     Abstract available

  32. SANDLIN RD, Wong KHK, Tessier SN, Swei A, et al
    Ultra-fast vitrification of patient-derived circulating tumor cell lines.
    PLoS One. 2018;13:e0192734.
    PubMed     Text format     Abstract available

  33. CHU LW, John EM, Yang B, Kurian AW, et al
    Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies.
    PLoS One. 2018;13:e0195666.
    PubMed     Text format     Abstract available

  34. NAM SY, Ko ES, Lim Y, Han BK, et al
    Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    PLoS One. 2018;13:e0195756.
    PubMed     Text format     Abstract available


    Radiology

  35. SEIDENWURM D, Breslau J
    Diagnostic Outcomes of Screening and Diagnostic Mammography.
    Radiology. 2017;284:610-611.
    PubMed     Text format    

  36. LEE JM, Miglioretti DL, Burnside ES, Morris EA, et al
    Mammography Performance Benchmarks in an Era of Value-based Care.
    Radiology. 2017;284:605-607.
    PubMed     Text format    

  37. TAYLOR-PHILLIPS S, Jenkinson D, Stinton C, Wallis MG, et al
    Double Reading in Breast Cancer Screening: Cohort Evaluation in the CO-OPS Trial.
    Radiology. 2018 Apr 10:171010. doi: 10.1148/radiol.2018171010.
    PubMed     Text format     Abstract available

  38. ROSENBERG RD, Seidenwurm D
    Breast Cancer Screening: Two (or Three) Heads Are Better than One?
    Radiology. 2018 Apr 10:180207. doi: 10.1148/radiol.2018180207.
    PubMed     Text format    


    Science

  39. RABESANDRATANA T
    U.K. moms are turning parenting into an experiment.
    Science. 2018;359:726-727.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: